Navigation Links
Tongjitang Files 2009 Annual Report on Form 20-F
Date:7/1/2010

SHENZHEN, China, July 1 /PRNewswire-Asia-FirstCall/ -- Tongjitang Chinese Medicines Company (the "Company"; NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced that it filed its Annual Report on Form 20-F for the year ended December 31, 2009 with the Securities and Exchange Commission on June 30, 2010. The Annual Report on Form 20-F can be accessed via the investor relations section of the Company's website at http://www.tongjitang.com .

The Company will provide a hard copy of its Annual Report on Form 20-F, including audited financial statements, free of charge to its shareholders and ADS holders upon request. Requests should be directed to the Company's Investor Relations contact at 203-682-8200.

About Tongjitang Chinese Medicines Company

Tongjitang Chinese Medicines Company, through its operating subsidiaries Tongjitang Pharmaceutical, Tongjitang Distribution, Tongjitang Chain Stores, Guizhou Long-Life Pharmaceutical Company Limited, Qinghai Pulante and Anhui Jingfang, is a vertically integrated specialty pharmaceutical company focused on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China. Tongjitang's principal executive offices are locat
'/>"/>

SOURCE Tongjitang Chinese Medicines Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Tongjitang Chinese Medicines Acquires Guiyang Liquor Factory
2. Tongjitang Chinese Medicines Company Reports First Quarter 2010 Financial Results
3. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
4. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
5. AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer
6. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
7. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
8. Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles
9. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
10. FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)
11. Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015 BioElectronics Corporation (OTC Pink: BIEL), ... Therapy medical devices, announced today that its registry ... trial device has been published in the prominent ... http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 chronic pain ... assessment.  Chronic pain is a ...
(Date:8/4/2015)... EDISON, N.J. , Aug. 4, 2015 /PRNewswire/ ... biopharmaceutical company focused on the development and commercialization ... Sapirstein , Chief Executive Officer, will present live ... DATE: Thursday, August 6, 2015 TIME: 12:15PM EDT ... will be a live, interactive online event where ...
(Date:8/4/2015)... 4, 2015  Ironshore Pharmaceuticals & Development, Inc. ... a company specializing in personalized medicine, to participate ... designed to evaluate the safety and efficacy of ... Attention-deficit/hyperactivity disorder (ADHD). This is Restore,s second clinical ... originally partnered with Ironshore in 2014 and continues ...
Breaking Medicine Technology:BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 3Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2
... voluntary recall of ALL lots of its Ketorolac Tromethamine Injection, USP ... NDC# 0517-0601-25 15 mg/mL ... This recall is in addition to the voluntary recall initiated on ... unexpired lots of Ketorolac Tromethamine Injection, USP, 30 mg/mL ...
... a next-generation oncology diagnostics company focused on improving ... closed a $21 million series A financing. ... and included Bessemer Venture Partners, Physic Ventures and ... ) , On-Q-ity is developing diagnostics to determine ...
Cached Medicine Technology:American Regent Expands Voluntary Recall to Include All Lots of Ketorolac Tromethamine Injection, USP 15 mg/mL; 1mL Single Dose Vials 2Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy 2
(Date:8/4/2015)... ... August 04, 2015 , ... They say a picture is ... health conditions, pictures and medical art can be essential. StayWell, a health solutions company, ... Krames Patient Education solutions have been used by physicians and other health care providers ...
(Date:8/4/2015)... ... August 04, 2015 , ... Increasingly, patients are researching online ... physician. In an effort to share more and better information with these savvy ... publicly share patient satisfaction ratings and comments about its doctors and advanced practice ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... design, product packaging, and fulfillment services, joined over 200 other Long Island-based corporations ... held on Tuesday, July 28th at Jones Beach State Park in Wantagh, New ...
(Date:8/4/2015)... ... August 04, 2015 , ... Patients are invited ... by the world renowned Beverly Hills facelift surgeon , Dr. Paul Nassif. ... techniques helps individuals to achieve an outer appearance that meets their personal goals. ...
(Date:8/4/2015)... & Montclair, NJ (PRWEB) , ... August 04, 2015 , ... ... program in Arts and Health, the first of its kind in New Jersey, which ... University’s College of the Arts and Graduate School partnered with Atlantic Health System, one ...
Breaking Medicine News(10 mins):Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3Health News:UPMC 1st in Pa. to Share Provider Ratings 2Health News:UPMC 1st in Pa. to Share Provider Ratings 3Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 2Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 3
... new review outlines potential pharmaceutical, dietary, surgical, and ... cancer among women in the United States, and ... says risk reduction strategies for women at average ... lifestyle factors. Among the recommendations: aside from following ...
... Kaiser Foundation Health Plan,Inc., Kaiser Foundation Hospitals and ... billion for the quarter ended September,30, 2008, compared ... year., KFHP/H,s operating income in the third ... the same quarter last year. Financial market,volatility impacted ...
... IRVING, Texas and LAKE FOREST, Ill., Nov. ... services company of VHA Inc.,University HealthSystem Consortium ... the leading provider of outsourced hospital pharmacy ... which PharMEDium,will serve as Novation,s contractor of ...
... Recurring Diluted FFO Per Share Increases 5.7% ... Diluted FAD Per Share Increases 1.9% ... NEWPORT BEACH, Calif., Nov. 4 Nationwide,Health Properties, Inc. (NYSE: NHP ) ... nine months ended,September 30, 2008., "Our third quarter results continue the positive ...
... Net Operating Revenues Increase 6.5% ... Continued Emphasis on Debt Reduction, BIRMINGHAM, Ala., ... its results of operations for the,third quarter ended September 30, ... for the third quarter of 2008 versus,$428.3 million for the ...
... been produced by,an organization not affiliated with our campaign. ... the ad., As we have stated previously, the ... But it is wrong for the Mormons to push,their ... the ballot box, We note Mr. Schubert has ...
Cached Medicine News:Health News:Kaiser Foundation Health Plan and Hospitals Report Third Quarter Results 2Health News:Kaiser Foundation Health Plan and Hospitals Report Third Quarter Results 3Health News:Kaiser Foundation Health Plan and Hospitals Report Third Quarter Results 4Health News:PharMEDium Agreement as Novation's Contractor for Outsourced Compounded Pharmacy Preparations 2Health News:NHP Reports Third Quarter 2008 Earnings 2Health News:NHP Reports Third Quarter 2008 Earnings 3Health News:NHP Reports Third Quarter 2008 Earnings 4Health News:NHP Reports Third Quarter 2008 Earnings 5Health News:NHP Reports Third Quarter 2008 Earnings 6Health News:NHP Reports Third Quarter 2008 Earnings 7Health News:NHP Reports Third Quarter 2008 Earnings 8Health News:NHP Reports Third Quarter 2008 Earnings 9Health News:NHP Reports Third Quarter 2008 Earnings 10Health News:NHP Reports Third Quarter 2008 Earnings 11Health News:NHP Reports Third Quarter 2008 Earnings 12Health News:NHP Reports Third Quarter 2008 Earnings 13Health News:NHP Reports Third Quarter 2008 Earnings 14Health News:NHP Reports Third Quarter 2008 Earnings 15Health News:NHP Reports Third Quarter 2008 Earnings 16Health News:HealthSouth Reports Results for Third Quarter Ended September 30, 2008 2Health News:HealthSouth Reports Results for Third Quarter Ended September 30, 2008 3Health News:HealthSouth Reports Results for Third Quarter Ended September 30, 2008 4Health News:HealthSouth Reports Results for Third Quarter Ended September 30, 2008 5Health News:HealthSouth Reports Results for Third Quarter Ended September 30, 2008 6Health News:HealthSouth Reports Results for Third Quarter Ended September 30, 2008 7Health News:HealthSouth Reports Results for Third Quarter Ended September 30, 2008 8Health News:HealthSouth Reports Results for Third Quarter Ended September 30, 2008 9Health News:HealthSouth Reports Results for Third Quarter Ended September 30, 2008 10Health News:HealthSouth Reports Results for Third Quarter Ended September 30, 2008 11Health News:HealthSouth Reports Results for Third Quarter Ended September 30, 2008 12Health News:HealthSouth Reports Results for Third Quarter Ended September 30, 2008 13Health News:HealthSouth Reports Results for Third Quarter Ended September 30, 2008 14Health News:HealthSouth Reports Results for Third Quarter Ended September 30, 2008 15Health News:HealthSouth Reports Results for Third Quarter Ended September 30, 2008 16Health News:HealthSouth Reports Results for Third Quarter Ended September 30, 2008 17
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: